Literature DB >> 24856979

Short-term morbidity and mortality of Indiana pouch, ileal conduit, and neobladder urinary diversion following radical cystectomy.

M Francesca Monn1, Hristos Z Kaimakliotis2, K Clint Cary2, Jose A Pedrosa2, Chandra K Flack2, Michael O Koch2, Richard Bihrle2.   

Abstract

PURPOSE: Literature surrounding Indiana pouch (IP) urinary diversion suggests a higher incidence of complications and longer operative time compared with ileal conduit (IC) and neobladder (NB). We sought to assess short-term complications of IP diversions compared with other diversions at our institution.
MATERIALS AND METHODS: Using institutional National Surgical Quality Improvement Program data, we identified radical cystectomy cases performed for bladder cancer at Indiana University from January 2011 until June 2013. During this time period, the National Surgical Quality Improvement Program randomly evaluated approximately 70% of radical cystectomies performed for urothelial carcinoma at our institution. Multivariable logistic regression was performed to identify factors associated with Clavien grade III-V complications.
RESULTS: A total of 233 cases were identified, 139 IC, 39 IP, and 55 NB. Mean (standard deviation) operative times for IC, IP, and NB were 257 (84), 383 (78), and 327 (88) minutes, respectively (P<0.001). Half of the patients required blood transfusion during the hospitalization. The overall rate of complications was significantly lower among NB (P = 0.009). Overall, 12% of patients developed a Clavien grade III-V complication, with no difference observed between groups (P = 0.884). After controlling for preoperative confounders, IP patients were not at increased odds of developing a Clavien III-V complication compared with IC (odds ratio = 1.38, P = 0.599).
CONCLUSIONS: At a high-volume center, the incidence of serious complications was similar between diversion types. IP patients were more likely to experience minor complications. Patients should be counseled regarding rates of short-term complications and blood transfusion.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; NSQIP; Radical cystectomy; Urinary diversion

Mesh:

Year:  2014        PMID: 24856979     DOI: 10.1016/j.urolonc.2014.04.009

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  5 in total

1.  Total cysto-prostatectomy: Technique description and results in 2 dogs.

Authors:  Nicholas Bacon; Carlos H de M Souza; Sarah Franz
Journal:  Can Vet J       Date:  2016-02       Impact factor: 1.008

2.  Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy.

Authors:  Bruno Nahar; Tulay Koru-Sengul; Feng Miao; Nachiketh Soodana Prakash; Vivek Venkatramani; Aliyah Gauri; David Alonzo; Mahmoud Alameddine; Sanjaya Swain; Sanoj Punnen; Chad Ritch; Dipen J Parekh; Mark L Gonzalgo
Journal:  World J Urol       Date:  2017-12-11       Impact factor: 4.226

Review 3.  A systematic review and meta-analysis of the long-term outcomes of ileal conduit and orthotopic neobladder urinary diversion.

Authors:  Eva Browne; Nathan Lawrentschuk; Greg S Jack; Niall F Davis
Journal:  Can Urol Assoc J       Date:  2021-01       Impact factor: 1.862

4.  The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology.

Authors:  Simone Albisinni; Marco Oderda; Laurent Fossion; Virginia Varca; Jens Rassweiler; Xavier Cathelineau; Piotr Chlosta; Alexandre De la Taille; Franco Gaboardi; Thierry Piechaud; Peter Rimington; Laurent Salomon; Rafael Sanchez-Salas; Jens-Uwe Stolzenburg; Dogu Teber; Roland Van Velthoven
Journal:  World J Urol       Date:  2015-07-02       Impact factor: 4.226

5.  Short-term morbidity and mortality following radical cystectomy: a systematic review.

Authors:  Sophia Liff Maibom; Ulla Nordström Joensen; Alicia Martin Poulsen; Henrik Kehlet; Klaus Brasso; Martin Andreas Røder
Journal:  BMJ Open       Date:  2021-04-14       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.